(Total Views: 42)
Posted On: 09/03/2025 10:35:49 AM
Post# of 40522

$CVM - CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline https://finance.yahoo.com/news/cel-sci-multik...;tsrc=twtr

